CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司 *

(Incorporated in the Cayman Islands with Limited Liability)

(Stock Code: 867)

FORM OF PROXY

Form of proxy for use by shareholders at the Annual General Meeting to be held at Queensway & Victoria, Level 3, JW Marriott Hotel, Pacific Place, 88 Queensway, Hong Kong on Tuesday, 27 April 2021 at 10:00 a.m. or any adjournment thereof.

I/WeNote 1

of being the registered holder ofsharesNote 2 of US$0.005 each in the share capital of China Medical System Holdings Limited (the "Company") hereby appoint the Chairman of the meeting (or any adjournment thereof) or

of

to act as my/our proxyNote 3 at the Annual General Meeting of theCompany to be held at Queensway & Victoria, Level 3, JW Marriott Hotel, Pacific Place, 88 Queensway, Hong Kong on Tuesday, 27 April 2021 at 10:00 a.m. or any adjournment thereof and to vote on my/our behalf as indicated belowNote 4 and if no such indication is given, as my/our proxy thinks fit.

As Ordinary Resolutions

For

Against

1

To review, consider and adopt the audited consolidated financial statements of the Group, the reports of the directors of the Company the "Director(s)" and the auditors of the Company for the year ended 31 December 2020

2

To approve the recommended final dividend of RMB0.2033 (equivalent to HK$0.243) per share for the year ended 31 December 2020

3

(a) To re-elect Ms. Chen Yanling as executive Director

(b) To re-elect Mr. Leung Chong Shun as independent non-executive Director

(c) To re-elect Ms. Luo, Laura Ying as independent non-executive Director

(d) To authorise the board of Directors to fix the Directors' remuneration

4

To re-appoint Deloitte Touche Tohmatsu as auditors of the Company and to authorise the board of Directors to fix their remuneration

5

To grant a general mandate to the Directors of the Company to allot, issue and otherwise deal with unissued shares of the Company#

6

To grant a general mandate to the Directors of the Company to repurchase shares of the Company#

7

To add the nominal amount of the shares repurchased by the Company to the general mandate granted to the Directors of the Company under resolution No.5 above#

Signature:

Notes 5,6,7

Date:

*For identification purpose only

Notes:

  • 1. Full name(s) and address(es) are to be inserted in BLOCK CAPITALS.

  • 2. Please insert the number of shares registered in your name(s) and to which this proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all the shares in the share capital of the Company registered in your name(s).

  • 3. If any proxy other than the Chairman of the meeting is preferred, please strike out "the Chairman of the meeting (or any adjournment thereof) or" and insert the name and address of the proxy desired in the space provided. A proxy need not be a shareholder of the Company.

  • 4. If you wish to vote for the resolution, please tick "√" the box marked "For". If you wish to vote against the resolution tick "√" the box marked "Against". Failure to tick either box will entitle your proxy to cast your vote or abstain at his/ her discretion on the resolution. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the meeting other than that referred to in the notice convening the meeting.

  • 5. This form of proxy must be signed by a shareholder, or his/her attorney duly authorized in writing, or if the shareholder is a corporation, either under its common seal or under the hand of an officer or attorney duly authorized in writing.

  • 6. In the case of joint registered holders of any shares, the vote of the senior holder who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders. For this purpose, seniority shall be determined by the order in which the names of the holders stand in the register of shares of the Company.

  • 7. To be valid this form of proxy together with any power of attorney or other authority, if any, under which it is signed (or a notarially certified copy of such power of attorney or authority) must be deposited at the Company's branch share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, on 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong as soon as possible and in any event not less than 48 hours before the time appointed for holding the meeting or any adjournment thereof.

  • 8. Any alteration made in this form must be initialed by the person(s) who sign(s) the form.

# The full text of the resolution is set out in the notice of annual general meeting dated 24 March 2021.

PERSONAL INFORMATION COLLECTION STATEMENT

  • (i) "Personal Data" in these statements has the same meaning as "personal data" in the Personal Data (Privacy) Ordinance, Chapter 486 of the Laws of Hong Kong ("PDPO").

  • (ii) The supply of your Personal Data to the Company and/or the Company's branch share registrar is on a voluntary basis and such data will be used for processing your instructions as stated in this Form of Proxy.

  • (iii) Your Personal Data will not be transferred to any third parties (other than the Company's branch share registrar) unless it is a requirement to do so by law, for example, in response to a court order or a law enforcement agency's request and will be retained for such period as may be necessary for our verification and record purposes.

  • (iv) You and your appointed proxy have the right to request access to and/or to correct the respective Personal Data in accordance with the provisions of the PDPO. Any such request should be in writing addressed to the Personal Data Privacy Officer of Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong.

Attachments

  • Original document
  • Permalink

Disclaimer

China Medical System Holdings Ltd. published this content on 24 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 March 2021 10:56:01 UTC.